Adenosine A2b Receptor Antikörper
Kurzübersicht für Adenosine A2b Receptor Antikörper (ABIN645965)
Target
Alle Adenosine A2b Receptor (ADORA2B) Antikörper anzeigenReaktivität
Wirt
Konjugat
Applikation
-
-
Produktmerkmale
- Goat Anti-Adenosine A2b Receptor
-
-
anti-Adenosine A2b Receptor (ADORA2B) (C-Term) antibody
Verified ADORA2B Reaktivität: Human ELISA, IHC, IF, FACS Wirt: Ziege Polyclonal unconjugated
anti-Adenosine A2b Receptor (ADORA2B) (AA 292-332) antibodyADORA2B Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Adenosine A2b Receptor (ADORA2B) (AA 251-300) antibodyADORA2B Reaktivität: Human, Maus, Ratte WB, FACS, IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Adenosine A2b Receptor (ADORA2B) (AA 101-200) antibodyADORA2B Reaktivität: Human, Maus, Ratte WB, FACS, IF (p), IHC (p), ICC, IF (cc), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Adenosine A2b Receptor (ADORA2B) (2nd Extracellular Loop), (AA 147-166), (C154S) antibodyKO Validated ADORA2B Reaktivität: Human WB, IHC, IF, FACS, LCI, IC Wirt: Kaninchen Polyclonal unconjugated
anti-Adenosine A2b Receptor (ADORA2B) (AA 100-200) antibodyADORA2B Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Adenosine A2b Receptor (ADORA2B) (C-Term) antibodyADORA2B Reaktivität: Human, Maus, Ratte WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Adenosine A2b Receptor (ADORA2B) (N-Term) antibodyADORA2B Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Adenosine A2b Receptor (ADORA2B) (AA 233-282) antibodyADORA2B Reaktivität: Human, Meerschweinchen WB Wirt: Kaninchen Polyclonal unconjugated
anti-Adenosine A2b Receptor (ADORA2B) (2nd Extracellular Loop), (AA 147-166), (C154S) antibody (APC)ADORA2B Reaktivität: Human FACS, LCI Wirt: Kaninchen Polyclonal APC
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
- Adenosine A2b Receptor (ADORA2B)
-
Andere Bezeichnung
- Adenosine A2b Receptor
-
Pathways
- cAMP Metabolic Process, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Target
-
